Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Clinical features and management of eyes with acute retinal necrosis presenting with rhegmatogenous retinal detachment.
Indian J Ophthalmol
January 2025
Uveitis and Retina Services, L V Prasad Eye Institute, GMR Varalakshmi Campus, Visakhapatnam, Andhra Pradesh, India.
Purpose: To study clinical features, anatomical and visual outcomes in eyes having rhegmatogenous retinal detachment (RD) as the presenting feature of acute retinal necrosis (ARN).
Materials And Methods: We conducted a retrospective cohort study of patients with ARN (active/healed) and concomitant RD at the presenting visit.
Results: The median age of patients was 36 years, with a male preponderance (9:1).
Cystoid macular edema following repeat DMEK: incidence and risk factors.
Graefes Arch Clin Exp Ophthalmol
November 2024
Department of Ophthalmology, Rothschild Foundation Hospital, Paris, France.
Purpose: To describe the incidence of CME in re-DMEK procedures and identify the associated risk factors.
Methods: Retrospective case series of 88 patients who underwent re-DMEK surgeries from January 2013 to October 2023. Surgical results were analyzed based on the cause of corneal decompensation, associated ophthalmologic factors, occurrence of CME after primary DMEK surgery, incidence of CME after re-DMEK, time interval between surgery and onset of CME, and management and outcomes of CME.
How Safe is Nd: YAG Laser Capsulotomy in Patients with Uveitis? Outcomes of a Long-Term Study.
J Curr Ophthalmol
October 2024
Department of Ophthalmology, GS Medical College and Hospital, Pilkhuwa, Uttar Pradesh, India.
Purpose: To study the outcomes and complications of Nd: YAG laser capsulotomy in patients with uveitis.
Methods: This study retrospectively evaluated outcomes of Nd: YAG laser capsulotomy in 260 eyes of 260 patients with uveitis. The main indications for performing capsulotomy were a visually significant posterior capsule opacification (PCO) and inability to visualize the posterior segment.
Persistent syphilitic ocular manifestations despite treatment: a case series.
J Ophthalmic Inflamm Infect
October 2024
Department of Ophthalmology, Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Article Synopsis
- Penicillin is the primary treatment for syphilis, but some patients experience ongoing eye issues like visual loss due to chronic inflammation or incomplete treatment.
- In a case series of three patients, two experienced persistent syphilitic retinal conditions despite being treated with penicillin, leading to additional treatments or reinforcement of therapy.
- Recommendations emerging from these cases emphasize ensuring complete initial penicillin treatment and monitoring inflammatory responses to optimize recovery and visual outcomes.
Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study.
Int J Retina Vitreous
September 2024
Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI), Ente Ospedaliero Cantonale (EOC), Via Pietro Capelli 1, Lugano, 6962, Switzerland.
Background: Intravitreal faricimab, a bispecific antibody targeting both angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A), was recently introduced for the treatment of neovascular age-related macular degeneration (nAMD), diabetic macular oedema and cystoid macular oedema secondary to retinal vein occlusion. The aim of our study was to assess the efficacy, safety and durability of intravitreal faricimab in a real-world cohort of treatment-naïve patients with nAMD.
Methods: Single-centre, prospective cohort study of 21 eyes from 19 treatment-naïve nAMD patients who were treated with intravitreal faricimab from October 2022 to April 2024.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!